Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
22,951.60
(
0.00%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
103.76
(
3.07%
)
Bitcoin
68,914.80
(
0.19%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mazlat10 post# 213937

Thursday, 09/28/2017 12:09:43 PM

Thursday, September 28, 2017 12:09:43 PM

Post# of 257295
DXCM—Some comments on the magnitude of the hit from ABT’s Freestyle Libre:

http://www.barrons.com/articles/dexcom-stay-sweet-or-go-sour-1506610819

What’s curious about DXCM’s recent price action is that FDA approval of ABT’s device was not unexpected.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today